ArticleHospital pharmacy2023
Seizures Following Self-Medication With Colloidal Silver: A Case Report.
Article in Hospital pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Dietary silver nanoparticle supplementation induces Alzheimer-like lesions through Bifidobacterium deficiency-dominated gut microbiota dysbiosis and neuroinflammation.NPJ science of food · 2026Article
- Prevalence and association of self-medication practices with personal and educational factors among university employees of Saudi Arabia: A cross-sectional study.Journal of family medicine and primary care · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver-containing products have been used for medicinal purposes since antiquity. Throughout the ages and indeed up until the present time, silver has been employed with the hopes of treating a myriad of diseases including the common cold, skin problems, infections, and even cancer. However, silver has no known biological role in human physiology, and taking silver may lead to adverse reactions. The better-known adverse reactions of silver include argyria, or a gray-blue cutaneous discoloration, which is a known effect of silver accumulation. Additionally renal or hepatic injury may also be experienced. Reports of neurological adverse reactions are rare, however, and the extant medical literature contains very few descriptions of such cases. We report herein a case of a 70 year old man who presented with seizures as the sole manifestation of silver toxicity after self-medicating with colloidal silver.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.